Contact lens manufacturer Safigel acquired by Rome-based Bruno Pharmaceuticals

Article

Contact lens maker Safigel was acquired by Bruno Pharmaceuticals S.P.A., a privately held, family owned, Italian pharmaceutical company based in Rome.

Chicago-Contact lens maker Safigel announced that the company was recently acquired by Bruno Pharmaceuticals S.P.A., a privately held, family owned, Italian pharmaceutical company based in Rome.

According to Safigel, Bruno shares a kindred synergy with Safigel’s mission, “to provide new, groundbreaking alternatives to eye-care professionals (ECPs) who fit patients with contact lenses, and to stay on the cutting-edge of bringing major technological innovations to the eye-care marketplace that benefit contact lens wearers.”

According to Vincenzo Bruno, Italian Chief Executive Officer, the two companies will “offer even more” to U.S. ECPs in the coming months.

Although details of the transaction were not disclosed, Safigel said in a statement that it will now expand its sales and marketing efforts on its sodium hyaluronate contact lens, which has seen steady growth.

For more articles in this issue of InDispensable, click here.

Recent Videos
Danielle Crull, ABOM, and Truffles of A Child's Eyes talk pediatric eye health and initiatives
Danielle Crull and Truffles the Kitty talk eye care initiatives for pediatric patients
World Sight Day 2024
Danielle Crull, ABOM, and Truffles of A Child's Eyes talk pediatric eye health and initiatives
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Khanh Hoang at EyeCon 2024 receiving the Visionary in Eye Care Award
Dr Adam Wenick at EyeCon 2024
David Chin Yee, MD, at EyeCon 2024
© 2024 MJH Life Sciences

All rights reserved.